Literature DB >> 5703868

[Effects of azathioprine ("Imuran") in Behcet's disease. Preliminary therapeutic results].

E Rosselet, Y Saudan, G Zenklusen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5703868     DOI： 10.1159/000305426

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN： 0030-3755            Impact factor:   3.250


× No keyword cloud information.
  8 in total

1.  Immunosuppressives in uveitis. A preliminary report of experience with chlorambucil.

Authors:  W J Dinning; E S Perkins
Journal:  Br J Ophthalmol       Date:  1975-08       Impact factor: 4.638

2.  Behçet's disease and the alimentary tract.

Authors:  J V Parkin; D G Wight
Journal:  Postgrad Med J       Date:  1975-04       Impact factor: 2.401

3.  Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease.

Authors:  C Besana; G Comi; A Del Maschio; L Praderio; A Vergani; S Medaglini; V Martinelli; F Triulzi; T Locatelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 4.  Oral ulceration and Behçet's syndrome.

Authors:  T Lehner
Journal:  Gut       Date:  1977-06       Impact factor: 23.059

5.  The colitis of Behcet's disease: a separate entity? Colonoscopic findings and literature review.

Authors:  G E Smith; L R Kime; J L Pitcher
Journal:  Am J Dig Dis       Date:  1973-11

Review 6.  Clinical use of immunosuppressive drugs: part I.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

7.  Cyclosporin in Behçet's disease: results in 16 patients after 24 months of therapy.

Authors:  M L Pacor; D Biasi; C Lunardi; P Cortina; P Caramaschi; D Girelli; M Botto; G Urbani; G Lombardo; L M Bambara
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

Review 8.  The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects.

Authors:  S Mishima; K Masuda; Y Izawa; M Mochizuki; K Namba
Journal:  Trans Am Ophthalmol Soc       Date:  1979
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.